Know Cancer

or
forgot password

    • cancer clinical trials in newport news, VA

    • Laparoscopic-Assisted Surgery Compared With Open Surgery in Treating Patients With Colon Cancer
    Virginia Oncology Associates - Newport News
    Newport News, Virginia 23606
    Colorectal Cancer
    Surgery to Remove Sentinel Lymph Nodes With or Without Removing Lymph Nodes in the Armpit in Treating Women With Breast Cancer
    Virginia Oncology Associates - Newport News
    Newport News, Virginia 23606
    Breast Cancer
    Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
    Riverside Regional Medical Center
    Newport News, Virginia 23601
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer
    Virginia Oncology Associates - Newport News
    Newport News, Virginia 23606
    Colorectal Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Peninsula Cancer Institute - Newport News Office
    Newport News, Virginia 23601
    Endometrial Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Peninsula Cancer Institute

    Trial Locations
    Peninsula Cancer Institute
    Peninsula Cancer Institute-Newport News
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    Peninsula Cancer Institute - Newport News Office
    Newport News, Virginia 23601
    Metastatic Cancer, Prostate Cancer
    Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)
    Virginia Oncology Associates Research Program
    Newport News, Virginia 23606
    Carcinoma, Non-Small-Cell Lung, Non-small Cell Lung Cancer, NSCLC
    A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Lymphoma, T-Cell, Peripheral
    PhII ICb With/Without Erbitux in MBC Pts
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Metastatic Breast Cancer
    A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
    Peninsula Cancer Institute
    Newport News, Virginia 23601
    Non-Small Cell Lung Cancer
    Multicenter Selective Lymphadenectomy Trial II (MSLT-II)
    Sentara Careplex Hospital
    Newport News, Virginia 23606
    Melanoma
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Peninsula Cancer Institute-Newport News

    Trial Locations
    Peninsula Cancer Institute-Newport News
    Sentara Surgery Specialists-Jefferson
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
    Peninsula Cancer Institute-Newport News
    Newport News, Virginia 23601
    Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
    A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Small Cell Lung Cancer, Non-small Cell Lung Cancer
    High-dose Bevacizumab in Advanced Renal Carcinoma Patients
    Peninsula Cancer Institute
    Newport News, Virginia 23601
    Renal Cancer, Kidney Cancer
    Adj TC + Herceptin Early Stage Breast Cancer
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Breast Cancer
    TAC Versus TC for Adjuvant Breast Cancer
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Breast Cancer
    Randomized Phase 3b Study in Previously Untreated Multiple Myeloma Patients: VELCADE,Thalidomide, and Dexamethasone Versus VELCADE and Dexamethasone Versus VELCADE, Melphalan, and Prednisone
    Virginia Oncology Associates

    Trial Locations
    Virginia Oncology Associates
    Peninsula Cancer Institute Riverside Cancer Center
    Multiple Myeloma
    Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myelogenous Leukemia
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myelogenous Leukemia (AML)
    Efficacy Study of ABR-215050 to Treat Prostate Cancer
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Prostate Cancer
    Phase II Sunitinib Prog Met AIPC
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Metastatic Prostate Cancer
    Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC
    Peninsula Cancer Institute
    Newport News, Virginia 23601
    Non-Small Cell Lung Cancer
    Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC)
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Androgen-independent Prostate Cancer
    Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer
    Peninsula Cancer Institute
    Newport News, Virginia 23601
    Thyroid Cancer
    A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer
    Peninsula Cancer Institute
    Newport News, Virginia 23601
    Breast Cancer
    RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM
    Peninsula Cancer Institute
    Newport News, Virginia 23601
    Glioblastoma Multiforme
    Gemzar, Cisp, Sunitinib Urothelial Ca
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Urothelial Cancer
    Efficacy and Safety of MORAb-003 in Subjects With Platinum-sensitive Ovarian Cancer in First Relapse
    Peninsula Cancer Institute - Riverside Gynecology Oncology
    Newport News, Virginia 23601
    Ovarian Cancer
    Sunitinib Non Small Cell Lung Cancer Patients Over 70
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Non Small Cell Lung Cancer
    Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer
    Peninsula Cancer Institute
    Newport News, Virginia 23601
    Metastatic Breast Cancer
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Peninsula Cancer Institute-Newport News
    Newport News, Virginia 23601
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Trial of the Combination of Bevacizumab and Everolimus in Patients With Refractory, Progressive Intracranial Meningioma
    Peninsula Cancer Institute
    Newport News, Virginia 23601
    Intracranial Meningioma
    Safety Study of PLX108-01 in Patients With Solid Tumors
    Virginia Oncology Associates
    Newport News, Virginia 23606
    At This Time, All Cohorts Are Closed to Enrollment With the Exception of the Pigmented Villo-nodular Synovitis (PVNS) Cohort.
    Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma
    Peninsula Cancer Institute
    Newport News, Virginia 23601
    Metastatic Melanoma
    Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast Cancer
    Peninsula Cancer Institute
    Newport News, Virginia 23601
    Metastatic Breast Cancer
    Study of Pazopanib and Doxil in Patients With Advanced Relapsed Platinum-Sensitive or Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Adenocarcinoma
    Peninsula Cancer Institute
    Newport News, Virginia 23601
    Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Carcinoma
    Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC
    Peninsula Cancer Institute
    Newport News, Virginia 23601
    Non-Small-Cell Lung Cancer
    PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Breast Cancer
    Ixabepilone + Carboplatin Metastatic Breast Cancer
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Metastatic Breast Cancer
    A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
    Peninsula Cancer Institute
    Newport News, Virginia 23601
    Extensive-Stage Small Cell Lung Cancer
    Triple Negative Breast Cancer Biomarker Study
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Metastatic Breast Cancer, Triple Negative Breast Cancer
    Study of PX-866 and Docetaxel in Solid Tumors
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Non Small Cell Lung Cancer (NSCLC), Squamous Cell Carcinoma of the Head and Neck (SCCHN)
    First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
    Virginia Oncology Associates
    Newport News, Virginia 23606
    Transitional Cell Carcinoma, Bladder Carcinoma, Urothelial Carcinoma
    A 5-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
    Peninsula Cancer Institute
    Newport News, Virginia 23601
    Sickle Cell Disease
    Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
    Peninsula Cancer Institute
    Newport News, Virginia 23601
    Chronic Myeloid Leukemia
    Phase 1 and 2 Study of PX-866 and Cetuximab
    Virginia Oncology Associates

    Trial Locations
    Virginia Oncology Associates
    Peninsula Cancer Institute
    Incurable Metastatic Colorectal Carcinoma, Incurable Progressive, Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
    A Study of MM-111 in Combination With Multiple Treatments in Patients With HER2 Positive Cancer
    Virginia Oncology Associates
    Newport News, Virginia 23606
    HER-2 Gene Amplification
    Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
    Peninsula Cancer Institute
    Newport News, Virginia 23601
    Glioblastoma Multiforme
    Epigenetics and Psychoneurologic Symptoms in Women With Breast Cancer
    Peninsula Cancer Institute
    Newport News, Virginia 23601
    Breast Cancer
    Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer
    Urology of Virginia
    Newport News, Virginia 23606
    Prostate Cancer